Cetrorelix Acetate for Injection Now Available

Share Facebook icon Twitter icon Linkedin icon
June 06, 2024

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Cetrorelix Acetate for Injection, 0.25 mg kits.

  • 71288-558-90 - Cetrorelix Acetate for Injection 0.25 mg kit

 

ABOUT CETRORELIX ACETATE INJECTION, 0.25 MG KIT

Cetrorelix Acetate for Injection is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian stimulation.

For full prescribing information, please click on the following link.



Learn more about Cetrorelix Acetate for Injection 

New Launches
Dacarbazine for Injection, USP Now Available

Dacarbazine for Injection, USP Now Available

 Meitheal Pharmaceuticals Announces Exclusive Commercial Licensing Agreement for YUSIMRY®

Meitheal Pharmaceuticals Announces Exclusive Commercial Licensing Agreement for YUSIMRY®
This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices